ShareValue scores for MEDICAMEQ.NSE: Valuation 57, Quality 36, Growth 37, Health 44.

MEDICAMEQ.NSE
NSE

Medicamen Biotech Limited

₹244.41(+0.53%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 17%
Valuation
57
Fair Value
Price vs Value
Quality
36
Weak
Business Strength
Growth
37
Weak
Revenue & Earnings
Health
44
Moderate
Financial Stability
Momentum
36
Bearish
Price Trend

Company Details

About

Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, sells, and distributes pharmaceutical formulations in India and internationally. The company offers drugs in various forms, including tablet, capsule, syrups, oral solution, and drops. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-malarials, vitamins, antibiotics, and supplements, other generics, and pain management. The company was incorporated in 1993 and is based in New Delhi, India.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026